Wang, H., Bi, H., Zhang, L., Li, H., Xue, F., Zhou, Z., . . . Lyu, P. (2019). Strategy changes in Chinese hematologists’ diagnosis and treatment of primary immune thrombocytopenia across 10 years (2009–2018). Chinese Medical Journal, 132(22), 2749-2750. https://doi.org/10.1097/CM9.0000000000000511
Chicago Style (17th ed.) CitationWang, Hong-Hui, Hui Bi, Lei Zhang, Hui-Yuan Li, Feng Xue, Ze-Ping Zhou, Ren-Chi Yang, and Peng Lyu. "Strategy Changes in Chinese Hematologists’ Diagnosis and Treatment of Primary Immune Thrombocytopenia Across 10 Years (2009–2018)." Chinese Medical Journal 132, no. 22 (2019): 2749-2750. https://doi.org/10.1097/CM9.0000000000000511.
MLA (9th ed.) CitationWang, Hong-Hui, et al. "Strategy Changes in Chinese Hematologists’ Diagnosis and Treatment of Primary Immune Thrombocytopenia Across 10 Years (2009–2018)." Chinese Medical Journal, vol. 132, no. 22, 2019, pp. 2749-2750, https://doi.org/10.1097/CM9.0000000000000511.